Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
Epidemiology and Infection|July 5, 2018
Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumoniaXinxing Zhang, Zhengrong Chen, Wenjing Gu, et al.BMC Infectious Diseases|April 18, 2025
Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, ChinaWenjing Gu, Zhuxia Li, Enze Han, et al.International Immunopharmacology|August 5, 2022
Foxp2 inhibits Th9 cell differentiation and attenuates allergic airway inflammation in a mouse model of ovalbumin-induced asthmaXinxing Zhang, Yu Ma, Yanyu He, et al.Frontiers in Oncology|October 30, 2024
Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancerXinyi Zhang, Xiaofei Chu, Jun Wang, et al.Bioorganic & Medicinal Chemistry Letters|November 28, 2024
Discovery of a selective and potent inhibitor of c-Jun N-terminal kinase 1 with anti-pulmonary fibrosis effectShuhua Ren, Fengling Liu, Man Chi, et al.BMC Infectious Diseases|May 21, 2020
Pathogen analysis of pertussis-like syndrome in childrenWenjing Gu, Kun Wang, Xinxing Zhang, et al.Bioorganic Chemistry|March 19, 2026
Design, synthesis, and biological evaluation of novel hydrophobic tag-based degraders targeting JNK1Yi Huang, Man Chi, Ye Zhang, et al.Virology Journal|March 20, 2022
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunityWenjing Gu, Hui Gan, Yu Ma, et al.Journal of Medicinal Chemistry|September 20, 2024
Structure Optimization of c-Jun N-terminal Kinase 1 Inhibitors for Treating Idiopathic Pulmonary FibrosisYi Huang, Fengling Liu, Shuhua Ren, et al.Respiratory Research|October 17, 2022
MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1Xingyu Rao, Heting Dong, Weili Zhang, et al.Pageof 9